Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
17.75
-0.23 (-1.28%)
Mar 13, 2026, 3:04 PM EDT - Market open
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$1,733,896
Market Cap
1.77B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 106 | 32 | 43.24% | 105 | 1 |
| Dec 31, 2024 | 74 | 17 | 29.82% | 74 | 0 |
| Dec 31, 2023 | 57 | 9 | 18.75% | 57 | 0 |
| Dec 31, 2022 | 48 | 7 | 17.07% | 48 | 0 |
| Dec 31, 2021 | 41 | 19 | 86.36% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Recursion Pharmaceuticals | 600 |
| Zymeworks | 264 |
| Relay Therapeutics | 192 |
| Soleno Therapeutics | 182 |
| Capricor Therapeutics | 160 |
| Pharvaris | 118 |
| AnaptysBio | 104 |
DFTX News
- 3 days ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 14 days ago - Definium Therapeutics, Inc. (DFTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates - Business Wire
- 17 days ago - Definium Therapeutics to Participate at Upcoming Investor Conferences - Business Wire
- 21 days ago - Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Business Wire
- 6 weeks ago - Definium Therapeutics Appoints Roger Adsett to Board of Directors - Business Wire
- 7 weeks ago - Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care - Business Wire
- 2 months ago - Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha